Question: is this a 2) strong advice, 1) weak advice 0) no advice?

It would be interesting to follow IPH and IgGSD patients as well as AFM over time (especially young individuals), to see whether their immunophenotype approaches that of patients with CVID. 
user
This is no advice
assistant